Does PIMAVANSERIN Cause Psychomotor hyperactivity? 105 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 105 reports of Psychomotor hyperactivity have been filed in association with PIMAVANSERIN (pimavanserin). This represents 0.2% of all adverse event reports for PIMAVANSERIN.
105
Reports of Psychomotor hyperactivity with PIMAVANSERIN
0.2%
of all PIMAVANSERIN reports
14
Deaths
16
Hospitalizations
How Dangerous Is Psychomotor hyperactivity From PIMAVANSERIN?
Of the 105 reports, 14 (13.3%) resulted in death, 16 (15.2%) required hospitalization.
Is Psychomotor hyperactivity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PIMAVANSERIN. However, 105 reports have been filed with the FAERS database.
What Other Side Effects Does PIMAVANSERIN Cause?
Hallucination (10,839)
Death (9,352)
Drug ineffective (5,545)
Product dose omission issue (3,808)
Confusional state (3,779)
Fall (3,366)
Delusion (2,421)
Hallucination, visual (1,954)
Gait disturbance (1,923)
Parkinson's disease (1,918)
What Other Drugs Cause Psychomotor hyperactivity?
METHYLPHENIDATE (617)
QUETIAPINE (412)
ARIPIPRAZOLE (389)
OLANZAPINE (366)
SERTRALINE (288)
MONTELUKAST (282)
RISPERIDONE (277)
LEVETIRACETAM (247)
VENLAFAXINE (214)
LEVOTHYROXINE (211)
Which PIMAVANSERIN Alternatives Have Lower Psychomotor hyperactivity Risk?
PIMAVANSERIN vs PIMECROLIMUS
PIMAVANSERIN vs PIMOZIDE
PIMAVANSERIN vs PINAVERIUM
PIMAVANSERIN vs PINDOLOL
PIMAVANSERIN vs PIOGLITAZONE